Additionally, pending of future studies is testing that the faster progression found in the pathological phenotype in double mutants is a consequence of the loss of CB1 receptor-mediated neuroprotective effects linked in ALS with BiP function as interacting protein. Here, HSPA5 is linked to amyotrophic lateral sclerosis.